trial

Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity

NCTId NCT07155096
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Enrolling By Invitation
Enrollment 40 (estimated)
Sponsored by Vanderbilt University Medical Center
Primary completion 2026-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Enrolling By Invitation
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Na
Model
Parallel
Masking
None
Start
2024-09-09
Primary completion
2026-06-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation

Sponsors

Vanderbilt University Medical CenterLead Sponsor

Investigators

1
Heather B Ward, MDPrincipal Investigator

Sites

1 total
Nashville, United States

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2026-06-30
Status
ENROLLING_BY_INVITATION
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation
drug
lead_sponsor
Vanderbilt University Medical Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Heather B Ward, MD
person